SHANGHAI UNIVERSAL BIOTECH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.74 CNY | -4.13% |
|
+6.96% | -14.78% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.2B 165M | Sales 2023 | 1.23B 169M | Capitalization | 3.33B 460M |
|---|---|---|---|---|---|
| Net income 2022 | 106M 14.65M | Net income 2023 | 40M 5.53M | EV / Sales 2022 | 1.99 x |
| Net cash position 2022 | 1.58B 219M | Net cash position 2023 * | - 0 | EV / Sales 2023 | 2.72 x |
| P/E ratio 2022 |
37.2
x | P/E ratio 2023 |
81.7
x | Employees | 688 |
| Yield 2022 |
1.97% | Yield 2023 |
-
| Free-Float | 30.51% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.13% | ||
| 1 week | +6.96% | ||
| Current month | +6.96% | ||
| 1 month | +6.58% | ||
| 3 months | +22.85% | ||
| 6 months | -23.04% | ||
| Current year | -14.78% |
1 week
30.78
38.30
1 month
26.6038.30
Current year
22.8138.93
1 year
22.8150.39
3 years
22.81136.00
5 years
22.81136.00
10 years
22.81136.00
| Managers | Title | Age | Since |
|---|---|---|---|
Zhao Wu Leng
CEO | Chief Executive Officer | 54 | 04-09-30 |
Min Tang
DFI | Director of Finance/CFO | 44 | 19-08-31 |
Yan Fang Qi
COO | Chief Operating Officer | 44 | 10-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lei Shi
BRD | Director/Board Member | 66 | 20-04-15 |
Jiang Hua Mei
BRD | Director/Board Member | 46 | 18-10-31 |
Yun Chen
BRD | Director/Board Member | 38 | 15-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 32.74 | -4.13% | 4,219,658 |
| 24-05-09 | 34.15 | -7.43% | 6,049,053 |
| 24-05-08 | 36.89 | +14.07% | 7,772,841 |
| 24-05-07 | 32.34 | +2.41% | 2,224,344 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes
Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The Company is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -14.78% | 393M | |
| +20.94% | 72.78B | |
| -1.26% | 24.24B | |
| +8.80% | 8.59B | |
| +8.25% | 8.38B | |
| -19.42% | 8.09B | |
| +6.17% | 4.81B | |
| +16.83% | 4.32B | |
| -1.83% | 4.05B | |
| +26.97% | 3.79B |
- Stock Market
- Equities
- 301166 Stock